Nutriband (NTRB) Competitors $7.90 +0.59 (+8.07%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$8.10 +0.20 (+2.53%) As of 01/30/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends NTRB vs. NVRO, INFU, TLSI, PDEX, SGHT, ZJYL, SRTS, TELA, ECOR, and LNSRShould you be buying Nutriband stock or one of its competitors? The main competitors of Nutriband include Nevro (NVRO), InfuSystem (INFU), TriSalus Life Sciences (TLSI), Pro-Dex (PDEX), Sight Sciences (SGHT), Jin Medical International (ZJYL), Sensus Healthcare (SRTS), TELA Bio (TELA), electroCore (ECOR), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Nutriband vs. Nevro InfuSystem TriSalus Life Sciences Pro-Dex Sight Sciences Jin Medical International Sensus Healthcare TELA Bio electroCore LENSAR Nevro (NYSE:NVRO) and Nutriband (NASDAQ:NTRB) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk. Do insiders & institutionals have more ownership in NVRO or NTRB? 95.5% of Nevro shares are held by institutional investors. Comparatively, 19.7% of Nutriband shares are held by institutional investors. 3.2% of Nevro shares are held by insiders. Comparatively, 54.1% of Nutriband shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts prefer NVRO or NTRB? Nevro presently has a consensus target price of $6.30, indicating a potential upside of 20.99%. Nutriband has a consensus target price of $13.00, indicating a potential upside of 64.56%. Given Nutriband's stronger consensus rating and higher possible upside, analysts clearly believe Nutriband is more favorable than Nevro.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nevro 3 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.77Nutriband 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, NVRO or NTRB? Nevro has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, Nutriband has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Is NVRO or NTRB more profitable? Nevro has a net margin of -16.54% compared to Nutriband's net margin of -338.51%. Nevro's return on equity of -23.52% beat Nutriband's return on equity.Company Net Margins Return on Equity Return on Assets Nevro-16.54% -23.52% -10.83% Nutriband -338.51%-54.49%-48.52% Does the MarketBeat Community prefer NVRO or NTRB? Nevro received 499 more outperform votes than Nutriband when rated by MarketBeat users. Likewise, 63.11% of users gave Nevro an outperform vote while only 44.44% of users gave Nutriband an outperform vote. CompanyUnderperformOutperformNevroOutperform Votes50363.11% Underperform Votes29436.89% NutribandOutperform Votes444.44% Underperform Votes555.56% Which has better earnings and valuation, NVRO or NTRB? Nutriband has lower revenue, but higher earnings than Nevro. Nutriband is trading at a lower price-to-earnings ratio than Nevro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNevro$425.17M0.46-$92.21M-$1.89-2.76Nutriband$2.09M41.99-$5.49M-$0.71-11.13 Does the media refer more to NVRO or NTRB? In the previous week, Nutriband had 10 more articles in the media than Nevro. MarketBeat recorded 10 mentions for Nutriband and 0 mentions for Nevro. Nevro's average media sentiment score of 1.43 beat Nutriband's score of 1.25 indicating that Nevro is being referred to more favorably in the media. Company Overall Sentiment Nevro Positive Nutriband Positive SummaryNevro and Nutriband tied by winning 9 of the 18 factors compared between the two stocks. Get Nutriband News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NTRB vs. The Competition Export to ExcelMetricNutribandSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$87.77M$10.23B$5.61B$9.14BDividend YieldN/A1.33%5.36%3.98%P/E Ratio-11.1319.9289.6917.66Price / Sales41.9928.461,216.4981.09Price / CashN/A23.5744.3437.71Price / Book10.825.885.134.73Net Income-$5.49M$182.72M$118.85M$225.42M7 Day Performance-7.39%0.46%1.40%0.75%1 Month Performance67.73%7.88%7.53%3.61%1 Year Performance202.68%2.06%26.68%21.42% Nutriband Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NTRBNutriband3.4693 of 5 stars$7.90+8.1%$13.00+64.6%+190.4%$87.77M$2.09M-11.1310Short Interest ↓Positive NewsNVRONevro2.0104 of 5 stars$4.57+1.6%$6.30+37.8%-68.7%$171.28M$425.17M-2.421,215Positive NewsINFUInfuSystemN/A$7.98-0.7%$13.00+62.9%N/A$169.66M$125.79M133.02410TLSITriSalus Life Sciences3.8328 of 5 stars$4.93+2.1%$11.79+139.1%-43.0%$150.32M$18.51M-1.98106Insider TradeGap DownPDEXPro-Dex3.6879 of 5 stars$44.35+0.0%$52.00+17.2%+90.9%$144.54M$56.80M28.80140Earnings ReportInsider TradeNews CoverageSGHTSight Sciences3.8036 of 5 stars$2.83-0.4%$4.72+66.8%-34.0%$143.65M$81.06M-2.77210High Trading VolumeZJYLJin Medical InternationalN/A$0.92-4.2%N/A-99.6%$142.60M$19.82M0.00245Short Interest ↓News CoverageGap UpSRTSSensus Healthcare3.5153 of 5 stars$6.56-2.5%$12.50+90.5%+107.6%$107.52M$24.41M11.5140Upcoming EarningsShort Interest ↑TELATELA Bio2.7323 of 5 stars$2.69+1.1%$9.25+243.9%-61.1%$105.96M$58.45M-1.59120ECORelectroCore2.9971 of 5 stars$15.90+1.3%$25.00+57.2%+106.2%$104.15M$16.03M-8.6950Short Interest ↓News CoverageLNSRLENSAR1.1636 of 5 stars$8.32-2.9%$8.00-3.8%+213.0%$96.60M$42.16M-5.70110Positive News Related Companies and Tools Related Companies Nevro Alternatives InfuSystem Alternatives TriSalus Life Sciences Alternatives Pro-Dex Alternatives Sight Sciences Alternatives Jin Medical International Alternatives Sensus Healthcare Alternatives TELA Bio Alternatives electroCore Alternatives LENSAR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NTRB) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
